TY PHAR.(002728.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
TY PHAR.
002728.SZ
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016.
2.805 T
002728.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking50/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE4.16%C
    • Profit Margin9.04%B
    • Gross Margin60.99%A
  • Growth ScoreC
    • Revenue YoY2.56%C
    • Net Profit YoY76.82%A
    • Total Assets YoY4.78%C
    • Net Assets YoY2.71%C
  • Cash ScoreB
    • Cash Flow Margin219.30%B
    • OCF YoY2.56%C
  • Operating ScoreC
    • Turnover0.37C
  • Debt ScoreA
    • Gearing Ratio20.65%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%

    Wallstreetcn·
    SZ
    000554
    -1.28%
    SZ
    301111
    +3.92%
    SZ
    002493
    -1.63%
    Wallstreetcn·
    SZ
    000554
    -1.28%
    SZ
    301111
    +3.92%
    SZ
    002493
    -1.63%

    February 6th Midday Review: ChiNext opened lower but rose to gain 0.65%, with chemical and robotics concept stocks collectively strengthening

    Wallstreetcn·
    SZ
    399006
    -0.16%
    SZ
    002728
    +0.11%
    SZ
    002440
    -0.21%
    Wallstreetcn·
    SZ
    399006
    -0.16%
    SZ
    002728
    +0.11%
    SZ
    002440
    -0.21%

    Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio Valley and LSPG rising over 10%

    Wallstreetcn·
    SZ
    301111
    +3.92%
    SZ
    002864
    +0.03%
    SZ
    002728
    +0.11%
    Wallstreetcn·
    SZ
    301111
    +3.92%
    SZ
    002864
    +0.03%
    SZ
    002728
    +0.11%

    The three major A-share indices of Shanghai and Shenzhen opened lower by 0.9% to 1.2%, with oil and gold stocks weak, while traditional Chinese medicine stocks rose against the trend

    AASTOCKS·
    SH
    600938
    +0.05%
    SH
    600489
    -0.88%
    SH
    600547
    -1.31%
    AASTOCKS·
    SH
    600938
    +0.05%
    SH
    600489
    -0.88%
    SH
    600547
    -1.31%

    TY PHAR. released its performance for the first three quarters, with a net profit attributable to the parent company of 65.2171 million yuan, a year-on-year increase of 985.18%

    Zhitong·
    SZ
    002728
    +0.11%
    Zhitong·
    SZ
    002728
    +0.11%
    © 2026 Longbridge｜Disclaimer